Medesis Pharma (France) Executives
| ALMDP Stock | EUR 0.35 0.01 2.94% |
Medesis Pharma employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 7 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Discussion of Medesis Pharma's management performance can provide insight into the enterprise performance.
| Solene Guilliot Insider Member Devel |
| JeanClaude Maurel Insider Pres CEO |
Medesis |
Medesis Pharma Management Team Effectiveness
Medesis Pharma's management efficiency ratios could be used to measure how well Medesis Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Medesis Pharma Workforce Comparison
Medesis Pharma SA is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 191. Medesis Pharma claims roughly 3.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
Medesis Pharma SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Medesis Pharma SA Price Series Summation is a cross summation of Medesis Pharma price series and its benchmark/peer.
Medesis Pharma Notable Stakeholders
A Medesis Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medesis Pharma often face trade-offs trying to please all of them. Medesis Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medesis Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Solene Guilliot | Member Devel | Profile | |
| JeanClaude Maurel | Pres CEO | Profile | |
| Tessa Olivato | Member Financial | Profile |
About Medesis Pharma Management Performance
The success or failure of an entity such as Medesis Pharma SA often depends on how effective the management is. Medesis Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medesis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medesis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. The company was founded in 2003 and is based in Montpellier, France. MEDESIS PHARMA is traded on Paris Stock Exchange in France.
Medesis Pharma Workforce Analysis
Traditionally, organizations such as Medesis Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medesis Pharma within its industry.Medesis Pharma Manpower Efficiency
Return on Medesis Pharma Manpower
| Revenue Per Employee | 31.9K | |
| Revenue Per Executive | 31.9K | |
| Net Loss Per Employee | 882.2K | |
| Net Loss Per Executive | 882.2K |
Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.